From the Editor-in-Chief
Research on premalignancy is needed to fully tap the potential of cancer interception.
by William G. Nelson, MD, PhD
Minimizing Chemotherapy-Related Nausea and Vomiting | Scanning Disparities | Doing More With Less | Watch Your Mouth | Support Services Help Improve Patient Outcomes | What’s Next?
Your Cancer Guide
As the pandemic continues, cancer patients and survivors must weight fears of possible infection with their need to live fully.
by Hester Hill Schnipper
Caregiving With Confidence
When a loved one has advanced cancer, it’s common to mourn the loss that hasn’t happened yet.
by Karen J. Bannan
Researchers study ways to improve telehealth capabilities, clinical trials and health disparities.
by Trevan Locke, PhD
Sophisticated blood tests offer a less invasive way to characterize cancers, guide treatment and catch recurrences sooner, but tissue biopsies remain the gold standard.
by Kendall K. Morgan
Cancer survivors have higher rates of depression than the general population, but many don’t know help is available.
by Cameron Walker
Rob Paulsen has voiced hundreds of animated characters, but as he prepared to return to a beloved role, cancer threatened his livelihood.
by Bradley Jones
New therapies provide hope and options for people as they monitor and manage this incurable blood cancer.
by Tara Haelle
Health Nuts | Clearing the Fog
Rebecca Dresser explores the history and burdens of clinical trials through the lens of a cancer survivor and medical ethicist.
by Marci A. Landsmann
Experts answer questions about limiting exposure to the coronavirus, how to talk about a cancer recurrence with loved ones, and strategies for dealing with a loss of health insurance.
Rich Nardiello seeks to bring a smile to children with cancer.
Facts and Stats
Data collected from cancer registries help chart the national burden of cancer.
Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.
by Kevin McLaughlin
Researchers are studying the effectiveness of drugs for treating COVID-19 in cancer patients who have been infected with the coronavirus.
by Marcus A. Banks
Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
Judy Pearson was surprised by the demands of cancer survivorship. Here, she offers tips on how to look at life after cancer.
by Judy Pearson
The AACR led a contingent of 130 organizations in asking that cancer patients and survivors be granted high priority in receiving COVID-19 vaccinations.
Eliminating disparities requires consistent effort on numerous fronts, including the development and sustenance of a diverse scientific workforce.
In March of last year, screenings for breast, colon and cervical cancer decreased by roughly 90% compared with historical rates.
Learning Medicare’s ABCDs
donate to the AACR